SCHEMBL3979150

SCHEMBL3979150

NP(N)(=S)NC1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.54
ALDH1A1 P00352 3/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP3A4 P08684 2/20 0.39
TP53 P04637 1/20 0.39
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
CA1 P00915 3/20 0.36
CA2 P00918 2/20 0.36
EPHX1 P07099 5/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
CA12 O43570 2/20 0.33
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH4 P08319 1/20 0.33
CA7 P43166 1/20 0.33
CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977872 1.00 GLA (0.54) GLAALDH1A1HSD17B10CYP3A4TP53
SCHEMBL3976091 1.00 GLA (0.54) GLAALDH1A1HSD17B10CYP3A4TP53
Diamidophosphate SCHEMBL29235170 0.89 GLA (0.45) GLAALDH1A1CYP3A4TP53LMNA
SCHEMBL3074205 0.78 GLA (0.58) GLAALDH1A1HSD17B10CYP3A4TP53
SCHEMBL10874038 0.74 ANPEP (0.44) GLAALDH1A1HSD17B10CYP3A4CA1
SCHEMBL6830631 0.74 GLA (0.54) GLAALDH1A1HSD17B10CYP3A4TP53
SCHEMBL6831668 0.74 GLA (0.54) GLAALDH1A1HSD17B10CYP3A4TP53
SCHEMBL10874395 0.74 GLA (0.54) GLAALDH1A1HSD17B10CYP3A4TP53
SCHEMBL11140411 0.70 GLA (0.50) GLAALDH1A1HSD17B10CYP3A4TP53
SCHEMBL3083276 0.70 GLA (0.40) GLAALDH1A1HSD17B10CYP3A4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4359368-A1 COMBINATION OF A PYRAZOLE AND A THIOPHOSPHORIC TRIAMIDE WockLab GmbH & Co. KG (DE) 2024-05-01 EP claimed
US-20230406821-A1 STRIGOLACTONE DERIVATIVES Plant Response, Inc. 2023-12-21 US claimed
US-11542211-B2 Agricultural microbial inoculant compositions and uses thereof Koch Agronomie Services, LLC (US) 2023-01-03 US claimed
WO-2022268777-A1 COMBINATION OF A PYRAZOLE AND A THIOPHOSPHORIC TRIAMIDE WOCKLAB GMBH & CO. KG (DE) 2022-12-29 WO claimed
US-20220177384-A1 REACTION PRODUCTS AND METHODS FOR MAKING AND USING THE SAME KOCH AGRONOMIC SERVICES, LLC (US) 2022-06-09 US claimed
EP-3472122-B1 COMPOSITIONS SUITABLE FOR USE IN MAKING FERTILIZERS, METHODS FOR MAKING SUCH COMPOSITIONS, AND METHOD FOR MAKING FERTILIZERS USING THE SAME MILLIKEN & CO (US) 2022-03-09 EP claimed
CN-109415278-B Compositions suitable for use in the preparation of fertilizers, methods of preparing these compositions, and methods of preparing fertilizers using the compositions 美利肯公司 2022-02-22 CN claimed
EP-2057258-A1 USE OF PHOSPHORIC TRIAMIDES IN CLEANER AND HYGIENE APPLICATIONS BASF SE (DE) 2009-05-13 EP claimed
EP-2056889-A1 USE OF PHOSPHORIC TRIAMIDES IN TOILETS BASF SE (DE) 2009-05-13 EP claimed
WO-2008022919-A1 USE OF PHOSPHORIC TRIAMIDES IN TOILETS BASF SE (DE) 2008-02-28 WO claimed
WO-2008022925-A1 USE OF PHOSPHORIC TRIAMIDES IN CLEANER AND HYGIENE APPLICATIONS BASF SE (DE) 2008-02-28 WO claimed
EP-0119487-B1 NOVEL N-ALIPHATIC AND N,N-ALIPHATIC PHOSPHORIC TRIAMIDE UREASE INHIBITORS AND UREASE INHIBITED UREA BASED FERTILIZER COMPOSITIONS ALLIED CORPORATION (US) 1986-07-16 EP claimed
US-12559437-B2 Agricultural compositions and methods for making and using the same KOCH AGRONOMIC SERVICES, LLC (US) 2026-02-24 US disclosed
US-20250276942-A1 UREASE INHIBITOR FORMULATION FOR USE IN UREA GRANULATION PROCESS BASF SE (DE) 2025-09-04 US disclosed
US-12331002-B2 Stabilized urea fertilizer compositions and methods for preparing same TESSENDERLO GROUP NV (BE) 2025-06-17 US disclosed
EP-4536612-A1 COMPOSITION COMPRISING A EUTECTIC MIXTURE COMPRISING AN ALKYLTHIOPHOSPHORIC TRIAMIDE UREASE INHIBITOR SPECIALTY OPERATIONS FRANCE (FR) 2025-04-16 EP disclosed
WO-2008022919-A1 USE OF PHOSPHORIC TRIAMIDES IN TOILETS BASF SE (DE) 2008-02-28 WO disclosed
WO-2008022925-A1 USE OF PHOSPHORIC TRIAMIDES IN CLEANER AND HYGIENE APPLICATIONS BASF SE (DE) 2008-02-28 WO disclosed
EP-1820788-A1 Preparations with improved urease-inhibiting properties and those preparations containing urea based fertilizers. BASF Aktiengesellschaft (DE) 2007-08-22 EP disclosed
WO-2007012581-A1 ODOUR-PREVENTING, WATER-ABSORBING COMPOSITIONS BASF SE (DE) 2007-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559437-B2 Agricultural compositions and methods for making and using the same PFAS, NAT1, HPD GLA 532/4885ALDH1A1 1127/4885HSD17B10 2536/4885
US-20230406821-A1 STRIGOLACTONE DERIVATIVES GRHPR, STS, SORD GLA 1261/4885ALDH1A1 1675/4885HSD17B10 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.